Initiated by psychiatrist or continuation of home therapy
If new start, confirmed insurance coverage outpatient
Unable to tolerate movement, metabolic, and/or immune side effects of other antipsychotics
Failure of at least one antipsychotic with lower side effect burden*
Aripiprazole
Brexpiprazole
Cariprazine
Lumateperone
Other partial D2 agonist
Note: Xanomeline-trospium has not been studied in treatment-resistant patients with schizophrenia or as adjunctive therapy as these populations were excluded from clinical trials
Formulary Restriction:
Note: Xanomeline-trospium has not been studied in treatment-resistant patients with schizophrenia or as adjunctive therapy as these populations were excluded from clinical trials